What Ever Happened to the Mysterious Nobel Prize Sperm Bank?
By Anna Silman,
The Cut
| 08. 01. 2019
Yesterday, the New York Times published a story about alleged sex trafficker and cartoon villain Jeffrey Epstein’s plan to “seed the human race with his DNA” by impregnating 20 women at once at his New Mexico ranch. According to one scientist, he got his idea from the Repository for Germinal Choice, a sperm bank that was designed to collect the sperm of Nobel Prize winners in order to fill the world with their genius offspring.
Wait — what?
While it sounds like something out of the movie Gattaca, the “Nobel Prize Sperm Bank” really was operational for 20 years, from 1979 to 1999, and based in Escondido, California. It was founded by the multimillionaire optometrist and inventor Robert Graham, an admirer of eugenics who believed the human race was getting progressively dumber and that the only way to stop it was by filling the world with the genetic descendants of Nobel Prize winners. As part of his utopian vision (or dystopian vision, depending on how you look at it), he also planned to recruit only married heterosexual...
Related Articles
By Aisha Down, The Guardian | 11.10.2025
It has been an excellent year for neurotech, if you ignore the people funding it. In August, a tiny brain implant successfully decoded the inner speech of paralysis patients. In October, an eye implant restored sight to patients who had...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...